356 related articles for article (PubMed ID: 25784216)
21. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations.
Pargal A; Kelkar MG; Nayak PJ
Biopharm Drug Dispos; 1996 Aug; 17(6):511-9. PubMed ID: 8866042
[TBL] [Abstract][Full Text] [Related]
22. The pharmacological profile of non-opioid (OTC) analgesics: aspirin, paracetamol (acetaminophen), ibuprofen, and phenazones.
Brune K
Agents Actions Suppl; 1988; 25():9-19. PubMed ID: 3066205
[TBL] [Abstract][Full Text] [Related]
23. A new rapidly absorbed paediatric paracetamol suspension. A six-way crossover pharmacokinetic study comparingthe rate and extent of paracetamol absorption from a new paracetamol suspension with two marketed paediatric formulations.
Smith S; Collaku A; Heaslip L; Yue Y; Starkey YY; Clarke G; Kronfeld N
Drug Dev Ind Pharm; 2012 Mar; 38(3):372-9. PubMed ID: 21961887
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
Desjardins PJ; Olugemo K; Solorio D; Young CL
Clin Ther; 2015 Feb; 37(2):448-61. PubMed ID: 25499666
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the analgesic and anti-inflammatory activity of fixed dose combination: non-steroidal anti-inflammatory drugs in experimental animals.
Lahoti A; Kalra BS; Tekur U
Indian J Dent Res; 2014; 25(5):551-4. PubMed ID: 25511049
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration.
Hanses A; Spahn-Langguth H; Meiss F; Mutschler E
Arzneimittelforschung; 1996 Jan; 46(1):57-63. PubMed ID: 8821519
[TBL] [Abstract][Full Text] [Related]
27. [Use of analgesics and aspirin in a Spanish multicenter study].
Fortuny J; Silverman D; Malats N; Tardón A; García-Closas R; Serra C; Carrato A; Rothman N; Dosemeci M; Kogevinas M
Gac Sanit; 2005; 19(4):316-20. PubMed ID: 16050968
[TBL] [Abstract][Full Text] [Related]
28. Phase I Pharmacokinetic Study of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in Healthy Adult and Adolescent Populations.
Tarabar S; Kelsh D; Vince B; Leyva R; Song D; Matschke K; Kellstein DE; Meeves S; Cruz-Rivera M
Drugs R D; 2020 Mar; 20(1):23-37. PubMed ID: 32130679
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers.
Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W
Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765
[TBL] [Abstract][Full Text] [Related]
30. NSAIDs: take with food or after fasting?
Rainsford KD; Bjarnason I
J Pharm Pharmacol; 2012 Apr; 64(4):465-9. PubMed ID: 22420652
[TBL] [Abstract][Full Text] [Related]
31. Bioavailability and pharmacokinetic profile of a newly-developed twice-a-day sustained-release paracetamol formulation.
Liu DJ; Collaku A; Youngberg SP
Int J Clin Pharmacol Ther; 2015 Feb; 53(2):172-81. PubMed ID: 25500485
[TBL] [Abstract][Full Text] [Related]
32. Influence of food on the pharmacokinetics of dipyrone.
Flusser D; Zylber-Katz E; Granit L; Levy M
Eur J Clin Pharmacol; 1988; 34(1):105-7. PubMed ID: 3360045
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and Bioavailability of a Fixed-Dose Combination of Ibuprofen and Paracetamol after Intravenous and Oral Administration.
Atkinson HC; Stanescu I; Frampton C; Salem II; Beasley CP; Robson R
Clin Drug Investig; 2015 Oct; 35(10):625-32. PubMed ID: 26334726
[TBL] [Abstract][Full Text] [Related]
34. Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects.
Lorier M; Magallanes L; Ibarra M; Guevara N; Vázquez M; Fagiolino P
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):787-793. PubMed ID: 26590950
[TBL] [Abstract][Full Text] [Related]
35. Effects of food intake on the pharmacokinetics of diclofenac potassium soft gelatin capsules: a single-dose, randomized, two-way crossover study.
Scallion R; Moore KA
Clin Ther; 2009 Oct; 31(10):2233-41. PubMed ID: 19922894
[TBL] [Abstract][Full Text] [Related]
36. [Analgesic efficacy and the tolerance for piroxicam-beta-cyclodextrin compared to piroxicam, paracetamol and placebo in the treatment of postextraction dental pain].
Dolci G; Ripari M; Pacifici L; Umile A
Minerva Stomatol; 1993 May; 42(5):235-41. PubMed ID: 8413108
[TBL] [Abstract][Full Text] [Related]
37. Does the placebo effect modulate drug bioavailability? Randomized cross-over studies of three drugs.
Hammami MM; Yusuf A; Shire FS; Hussein R; Al-Swayeh R
J Negat Results Biomed; 2017 May; 16(1):10. PubMed ID: 28535819
[TBL] [Abstract][Full Text] [Related]
38. Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol.
Litalien C; Jacqz-Aigrain E
Paediatr Drugs; 2001; 3(11):817-58. PubMed ID: 11735667
[TBL] [Abstract][Full Text] [Related]
39. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form.
Souliman S; Blanquet S; Beyssac E; Cardot JM
Eur J Pharm Sci; 2006 Jan; 27(1):72-9. PubMed ID: 16169713
[TBL] [Abstract][Full Text] [Related]
40. Single-dose pharmacokinetics of 2 or 3 tablets of biphasic immediate-release/extended-release hydrocodone bitartrate/acetaminophen (MNK-155) under fed and fasted conditions: two randomized open-label trials.
Devarakonda K; Kostenbader K; Giuliani MJ; Young JL
BMC Pharmacol Toxicol; 2015 Nov; 16():31. PubMed ID: 26614499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
